Furthermore, it seems that the sum of Kindlin-1 and Kindlin-2 remains constant in an NSCLC patient, thus the biological role of the molecular switch between Kindlin-1 and Kindlin-2 leaves an open question for future investigations. This evidence concerns the gene FERMT2 and non-small cell lung carcinoma.